ALPHATREX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Alphatrex, and when can generic versions of Alphatrex launch?
Alphatrex is a drug marketed by Savage Labs and is included in three NDAs.
The generic ingredient in ALPHATREX is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alphatrex
A generic version of ALPHATREX was approved as betamethasone dipropionate by FOUGERA PHARMS on June 26th, 1984.
Summary for ALPHATREX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Patent Applications: | 5,410 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ALPHATREX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ALPHATREX
US Patents and Regulatory Information for ALPHATREX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Savage Labs | ALPHATREX | betamethasone dipropionate | CREAM;TOPICAL | 019138-001 | Jun 26, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Savage Labs | ALPHATREX | betamethasone dipropionate | LOTION;TOPICAL | 070273-001 | Aug 12, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Savage Labs | ALPHATREX | betamethasone dipropionate | OINTMENT;TOPICAL | 019143-001 | Sep 4, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |